AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys (Q85216626)
Jump to navigation
Jump to search
scientific article published on 22 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys |
scientific article published on 22 May 2014 |
Statements
AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys (English)
Thérèse Di Paolo
Laurent Grégoire
Dominik Feuerbach
Walid Elbast
Markus Weiss
Baltazar Gomez-Mancilla